147 related articles for article (PubMed ID: 33041812)
1. CU06-1004 Alleviates Experimental Colitis by Modulating Colonic Vessel Dysfunction.
Kim YS; Zhang H; Lee S; Park S; Noh M; Kim YM; Kwon YG
Front Pharmacol; 2020; 11():571266. PubMed ID: 33041812
[TBL] [Abstract][Full Text] [Related]
2. CU06-1004 alleviates vascular hyperpermeability in a murine model of hereditary angioedema by protecting the endothelium.
Lee S; Kim Y; Kim YS; Zhang H; Noh M; Kwon YG
Allergy; 2023 May; 78(5):1333-1346. PubMed ID: 36789476
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of CU06-1004 via regulation of inflammation and endothelial permeability in LPS-induced acute lung injury.
Kim Y; Bae CR; Kim D; Kim H; Lee S; Zhang H; Noh M; Kim YM; Mochizuki N; Kwon YG
J Inflamm (Lond); 2023 Apr; 20(1):13. PubMed ID: 37024954
[TBL] [Abstract][Full Text] [Related]
4. CU06-1004 alleviates oxidative stress and inflammation on folic acid-induced acute kidney injury in mice.
Bae CR; Kim Y; Kwon YG
J Pharmacol Sci; 2024 Feb; 154(2):77-85. PubMed ID: 38246731
[TBL] [Abstract][Full Text] [Related]
5. Long-term administration of CU06-1004 ameliorates cerebrovascular aging and BBB injury in aging mouse model.
Kim H; Noh M; Zhang H; Kim Y; Park S; Park J; Kwon YG
Fluids Barriers CNS; 2023 Feb; 20(1):9. PubMed ID: 36726154
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of a hydroxynaphthoquinone fraction on dextran sulfate sodium-induced ulcerative colitis.
Zhang ZL; Fan HY; Yang MY; Zhang ZK; Liu K
World J Gastroenterol; 2014 Nov; 20(41):15310-8. PubMed ID: 25386079
[TBL] [Abstract][Full Text] [Related]
7.
Kim KY; Oh TW; Do HJ; Yang JH; Yang IJ; Jeon YH; Go YH; Ahn SC; Ma JY; Park KI
J Immunol Res; 2018; 2018():5718396. PubMed ID: 30402509
[TBL] [Abstract][Full Text] [Related]
8. Fermented barley and soybean (BS) mixture enhances intestinal barrier function in dextran sulfate sodium (DSS)-induced colitis mouse model.
Woo JK; Choi S; Kang JH; Kim DE; Hurh BS; Jeon JE; Kim SY; Oh SH
BMC Complement Altern Med; 2016 Dec; 16(1):498. PubMed ID: 27912750
[TBL] [Abstract][Full Text] [Related]
9. Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK/pMLC2 pathway.
Huang S; Fu Y; Xu B; Liu C; Wang Q; Luo S; Nong F; Wang X; Huang S; Chen J; Zhou L; Luo X
Phytomedicine; 2020 Mar; 68():153179. PubMed ID: 32062328
[TBL] [Abstract][Full Text] [Related]
10. Effects of 17β-Estradiol on Colonic Permeability and Inflammation in an Azoxymethane/Dextran Sulfate Sodium-Induced Colitis Mouse Model.
Song CH; Kim N; Sohn SH; Lee SM; Nam RH; Na HY; Lee DH; Surh YJ
Gut Liver; 2018 Nov; 12(6):682-693. PubMed ID: 30400733
[TBL] [Abstract][Full Text] [Related]
11. COMP-angiopoietin-1 ameliorates inflammation-induced lymphangiogenesis in dextran sulfate sodium (DSS)-induced colitis model.
Lee AS; Sung MJ; Kim W; Jung YJ
J Mol Med (Berl); 2018 May; 96(5):459-467. PubMed ID: 29610929
[TBL] [Abstract][Full Text] [Related]
12. CU06-1004 enhances vascular integrity and improves cardiac remodeling by suppressing edema and inflammation in myocardial ischemia-reperfusion injury.
Zhang H; Kim H; Park BW; Noh M; Kim Y; Park J; Park JH; Kim JJ; Sim WS; Ban K; Park HJ; Kwon YG
Exp Mol Med; 2022 Jan; 54(1):23-34. PubMed ID: 34997212
[TBL] [Abstract][Full Text] [Related]
13. Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis?
Gonçalves Fda C; Schneider N; Pinto FO; Meyer FS; Visioli F; Pfaffenseller B; Lopez PL; Passos EP; Cirne-Lima EO; Meurer L; Paz AH
World J Gastroenterol; 2014 Dec; 20(48):18228-39. PubMed ID: 25561790
[TBL] [Abstract][Full Text] [Related]
14. Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis.
Zhao HW; Yue YH; Han H; Chen XL; Lu YG; Zheng JM; Hou HT; Lang XM; He LL; Hu QL; Dun ZQ
World J Gastroenterol; 2017 Feb; 23(6):999-1009. PubMed ID: 28246473
[TBL] [Abstract][Full Text] [Related]
15. CU06-1004 as a promising strategy to improve anti-cancer drug efficacy by preventing vascular leaky syndrome.
Park S; Lee S; Kim D; Kim H; Kwon YG
Front Pharmacol; 2023; 14():1242970. PubMed ID: 37711172
[No Abstract] [Full Text] [Related]
16. Restoration of mucosal integrity and epithelial transport function by concomitant anti-TNFα treatment in chronic DSS-induced colitis.
Lenzen H; Qian J; Manns MP; Seidler U; Jörns A
J Mol Med (Berl); 2018 Aug; 96(8):831-843. PubMed ID: 29967942
[TBL] [Abstract][Full Text] [Related]
17. Temporal clinical, proteomic, histological and cellular immune responses of dextran sulfate sodium-induced acute colitis.
Nunes NS; Kim S; Sundby M; Chandran P; Burks SR; Paz AH; Frank JA
World J Gastroenterol; 2018 Oct; 24(38):4341-4355. PubMed ID: 30344419
[TBL] [Abstract][Full Text] [Related]
18. Berberine alleviates dextran sodium sulfate-induced colitis by improving intestinal barrier function and reducing inflammation and oxidative stress.
Zhang LC; Wang Y; Tong LC; Sun S; Liu WY; Zhang S; Wang RM; Wang ZB; Li L
Exp Ther Med; 2017 Jun; 13(6):3374-3382. PubMed ID: 28587416
[TBL] [Abstract][Full Text] [Related]
19. The Probiotic, ID-JPL934, Attenuates Dextran Sulfate Sodium-Induced Colitis in Mice Through Inhibition of Proinflammatory Cytokines Expression.
Je IG; Lee DG; Jeong DG; Hong D; Yoon JM; Moon JS; Park S
J Med Food; 2018 Sep; 21(9):858-865. PubMed ID: 30036104
[TBL] [Abstract][Full Text] [Related]
20. Decay-accelerating factor deficiency increases susceptibility to dextran sulfate sodium-induced colitis: role for complement in inflammatory bowel disease.
Lin F; Spencer D; Hatala DA; Levine AD; Medof ME
J Immunol; 2004 Mar; 172(6):3836-41. PubMed ID: 15004190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
